GlassScriptPhysician profile
Danielle L Hashmi
NPI 1972995389
$1,426.58
in general payments reported to CMS, 2019-2025
8 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $32.65 · 2022: $337 · 2023: $314 · 2024: $539 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $525.33 | 2021-2025 | Novosorb Btm |
| Smith+Nephew, INC. | $465.44 | 2022-2024 | Versajet, Acticoat 4" X 4", Oasis |
| Kerecis Limited | $122.25 | 2023-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $80.12 | 2021-2024 | Integra, Surgimend, Omnigraft |
| Avita Medical Americas, LLC | $80.12 | 2023-2025 | Recell, Cohealyx, Permeaderm |
| Haemonetics Corporation | $77.76 | 2022 | |
| Medline Industries LP | $45.31 | 2022-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.25 | 2023 | Gattex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Hashmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.